Stabilization of Gas Bubbles Released from Water-Soluble Carbohydrates Using Amphiphilic Compounds: Preparation of Formulations and Acoustic Monitoring of Bubble Lifetime by Hoff, Lars et al.
ORIGINAL ARTICLE
Stabilization of Gas Bubbles Released from Water-Soluble
Carbohydrates Using Amphiphilic Compounds: Preparation
of Formulations and Acoustic Monitoring of Bubble Lifetime
Lars Hoff • Per A. Foss • Knut Dyrstad •
Jo Klaveness • Pa ˚l Rongved
Received: 20 July 2010/Accepted: 20 January 2011/Published online: 13 February 2011
 The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract The ultrasound contrast agents Echovist
 and
Levovist
 (Bayer AG, Schering AG, Germany) are based
on the release of gas bubbles from milled a-D-galactose. In
diagnostic ultrasound, for this class of contrast agents, there
is a need for prolonged contrast duration. To investigate if
new carbohydrate compositions could prolong the lifetime
of the gas bubbles, a-D-galactose was mixed with other
carbohydrates or amphiphiles with varying log P. Acoustic
attenuation vs. time (390 s) area under the curve (A390) and
bubble half-time (t) were used as measures of prolonged
lifetime of gas bubbles. The products, to which 0.1% of a
lipophilic carboxylic acid (5b-cholanic acid, behenic acid,
and melissic acid) has been added, showed more than 5, 7
and 11 times enhancement of A390, respectively, compared
with the reference compound 2 (RC2) corresponding to the
commercial product Levovist. The half-time t  of the
same compounds was prolonged more than 6 times com-
pared with RC2. A partial least square (PLS) statistical
analysis conﬁrmed that, for additives, high log P carboxylic
acids lead to the highest A390. The present results bear a
promise of products with a more persistent in vivo ultra-
sound contrast effect than the commercially available
agents.
Keywords Gas bubbles  Ultrasound  Contrast agents 
Carbohydrates  Gas-release  Amphiphiles  Colloid 
Fatty acids  Acoustics
Introduction
Gas bubbles in the micrometer range are ideal contrast
agents for ultrasound imaging because of their high com-
pressibility and low density, giving excellent reﬂectance of
ultrasound waves (acoustic backscatter) [1]. Ultrasound
contrast signals from free gas bubbles in vivo in the human
heart were ﬁrst observed in 1968 after direct intracardiac
injection [2]. Short bubble lifetime urged development of
more stable agents giving more persistent contrast on the
arterial side after intravenous injection and passage through
the lung capillaries. The ultimate goal is to generate contrast
in the heart muscle (myocardium). Suspensions of solid
particles, emulsiﬁed liquid droplets, free and encapsulated
gases or liquids [3] have been proposed as ultrasound
contrast agents (USCA). Efﬁcient USCA may comprise
micron-sized bubbles stabilized by a thin, potentially bio-
degradable ﬂexible membrane consisting of polymers [4]o r
phospholipids [5]. However, carbohydrate-based gas-
releasing systems, generating free gas bubbles after intra-
venous injection of a particle suspension, eliminate the
challenge of developing a stabilized bubble suspension as a
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the commercially available agent SHU 454 (Echovist,
Schering AG, Berlin), milled, particulate water-soluble
a-D-galactose acts as a precursor for gas bubbles, and is in
clinical use in enhanced hystero-sonography [6]. The gas-
releasing powder is prepared using ball-milling of com-
mercial a-D-galactose, giving clusters of particles with a
mean size of about 40 lm, with air-ﬁlled voids between
them [7]. Upon dissolution in water, the clusters release the
air trapped in the clusters and gas bubbles are generated.
The a-D-galactose crystals dissolve in the water phase while
acting as short-living nucleation sites for the gas bubbles
[7]. Lack of myocardial contrast enhancement (MCE) with
SHU 454 in humans led to the improved agent SHU 508
(Levovist, Schering AG, Berlin), wherein a-D-galactose is
milled with 0.1% palmitic acid [8]. However, in spite of
more persisting contrast on the arterial side of the heart with
SHU 508 [9], it is not in clinical use to study early reduced
blood ﬂow in the myocardium using MCE. Since pre-
formed, lyophilized phospholipid-stabilized gas bubbles on
the market have been a success [10], the simplicity of the
gas-releasing carbohydrate-based products in the form of a
dry, particulate, water-soluble precursor of gas bubbles
encouraging further research. In the present research, our
ﬁrst aim was to investigate if lifetime of the populations of
gas bubbles released could be prolonged, by investigating a
broad range of amphiphilic compounds. Our second aim
was to investigate if acoustic attenuation vs. time (390 s)
area under the curve could be used as a suitable screening
tool in this research.
Experimental Section
Materials
Chemicals
Starch was purchased from Reppal PSM 70, Reppe Glykos
(Sweden). a-D-Xylose was purchased from BDH (Basel,
Switzerland). 1,2-dipalmitoyl-sn-glycero-3-phosphati-
dylcholine (DPPC) and 1,2-dioleoyl-sn-glycero-3-phos-
phatidylethanolamine (DOPE) were purchased from Avanti
Polar Lipids, USA. Human serum albumin (HSA), sodium
dodecyl sulfate (Sodium lauryl sulfate, Na-LS), 2-sul-
fobutanedioic acid 1,4-bis(2-ethylhexyl) ester sodium
salt (Na-docusate), Pluronic
 F68 (Mw 8.4 kDa) a very
hydrophilic polyoxyethylene polyoxypropylene triblock
copolymer (abbreviated HTBCP), sorbitan mono-oleate
isomer mixture (Span 80) abbreviated SMO, sorbitan tri-
oleate isomer mixture Span 85) abbreviated STO, a-lino-
lenic acid ((Z,Z,Z)-9,12,15-octadecatrienoic acid) and other
fatty acids were purchased from Sigma Chemical Company
(St. Louis, MO). Tricosa-10,12-diynoic acid was purchased
from ABCR GmbH & Co. (Karlsruhe, Germany). Hexa-
decanedioic acid, a-cyclodextrin, dextran (Mw 20 kD),
maltodextrin, glycogen, a-D-galactose and all other chem-
icals were purchased from Fluka Chemie AG (Buchs,
Switzerland) or E. Merck AG (Darmstadt, Germany).
Scheme 1 gives the structures of the used compounds
except for the oligo and polysaccharides. Deionized water
was used throughout the experiments. Chemical structures
and names of the compounds used in the present work are
given in Scheme 1.
Visual Inspection of the Products After Suspension
in the Carrier Liquid
Screening of the rough ability of the products to release gas
microbubbles was performed using conventional light
microscopy.
Area Under the Curve of Acoustic Attenuation
and Bubble Half-Time
A carrier liquid for determining the acoustic attenuation of
the products consisted of 10 mL of propylene glycol mixed
with 90 mL of 5% dextrose in water. Each product (1.0 g)
was dispersed in the carrier liquid (3.0 mL) and gently
handshaken for 15 s. The resulting mixture was added to
5% human serum albumin in phosphate buffer (52 mL).
The mixture was placed in a measurement cell with a
5 MHz broadband transducer mounted on one side wall,
and an ultrasound-reﬂecting plate on the opposite side of
the cell. A pulse-reﬂection technique measuring the
acoustic transmission through the product dispersions was
used to calculate the acoustic attenuation taken as the
inverse value of the measured acoustic transmission. The
acoustic attenuation (dB/cm) was plotted as a function of
time for 390 s. Temperature in the measurement cell was
37 ± 1 C with constant circulation of the liquid. The
results were normalized with regards to measurements of a
reference consisting of 55 mL of 5% human serum albu-
min buffer solution. The calculated integral of the area A
under the curve of acoustic attenuation vs. time (390 s),
was denoted A390. This parameter expressed the total
amount of gas phase in the dispersions up to and including
390 s. Average bubble lifetime was characterized by the
half-time (t) of the acoustic attenuation up to 390 s. Both
A390 and t were necessary to decide if persistence of
ultrasound contrast effect in vitro was improved for the
various formulations compared with the reference stan-
dards (deﬁned below).
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The particle size distribution of selected products was
analyzed using a Coulter Counter LS 100 or a Malvern
Mastersizer light-scattering apparatus by suspending
2 g of the product using a vibrating screen before
measuring.
Monitoring of Amphiphiles
The surfactants, phospholipids and fatty acids milled with the
carbohydrates were monitored by analyzing the product
(1.0 g) in carrier liquid (3 mL) using thin layer chromatog-
raphy(TLC) anddetecting spots usingNileblueﬂuorescence
and copper complexation as described in the literature [11].
Scheme 1 Chemical structures and names of the compounds used. The structures of starch, a-cyclodextrin, dextran Mw 20 kD, maltodextrin and
glycogen are omitted for clarity
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The concept of hydrophilic-lipophilic balance (HLB) is
based on calculations of the ratio of hydrophilic and lipo-
philic groups in the molecules [12]. However, HLB values
approach zero for many of the compounds used in the
present study with low water solubility. Therefore calcu-
lated log P was found to be a more useful parameter char-
acterizing the amphiphiles used herein. The log P values of
the amphiphilic compounds were calculated using the
chemist drawing and calculation software ChemBioDraw,
version 11.0.1, CambridgeSoft Europe Ofﬁce, 1 Signet
Court, Swanns Road, Cambridge CB5 8LA UK.
Data Analysis
The parameters deﬁned below were used (abbreviations in
parentheses) in a partial least squares analysis (PLS) model
with A390 as a response parameter: % (w/w) amphiphilic
material added (% amph); calculated log P of the amphi-
philes (log P); ionic character in sodium salt form (ionicity:
0 or 1); mean particle size in freshly prepared suspensions
(psize); % (w/w) a-D-galactose (%Gal); molecular weight
of the amphiphilic additive (LipidMw); degree of unsatu-
ration in the additives as number of double bond equiva-
lents (Unsat: 1–4); number of rings in the chemical
structure of the amphiphile (rings); presence of carboxylic
acid groups (Carboxyl: 0 or 1). The PLS analysis was
performed using the computer program Unscrambler, ver-
sion 7.01 from CAMO Software AS, Oslo, Norway.
Preparation of Products
All concentrations are given as % w/w in the procedures.
Two literature procedures for preparation of carbohydrate-
based gas-releasing ultrasound contrast agents [7, 13] were
modiﬁed to establish the three general preparation proce-
dures below. Ball-milling was performed with a Retsch
centrifugal ball-mill in a stainless steel ball-mill having a
50 mL grinding cup and 3 9 20 mm balls for 10 min. All
products appeared as white powders after milling.
General Procedure I: Mixtures of Carbohydrates Without
Amphiphiles Added, Products 1–4
Products (1) and (2) consisted of commercial qualities of
a-D-galactose (1) and a-D-xylose, respectively, that were
ball-milled. The a-D-galactose/Starch Mixtures (3a-c) were
prepared by mixing a-D-galactose (3.2, 2.0 and 0.8 g) with
starch (0.8, 2.0, and 3.2 g, respectively) followed by ball-
milling. The a-D-galactose/Dextran (Mw 20 kD) mixtures
(4a-b) were prepared by combining 25.8% solutions of
a-D-galactose in water (29.2 and 19.4 g) with 25.7%
solutions of Dextran in water (9.7 and 19.4 g, respectively).
The combined solutions were evaporated to dryness while
stirring under reduced pressure (10 Torr, 40 C) and dried
in a desiccator overnight. The products were then ball-
milled. Experimental data and results for products 1–4 are
given in Table 1.
General Procedure II: a-D-galactose-Based Products
with Surfactants (5–11) and Lipophilic Acids (12–19)
For each of the products 5–19, the amphiphilic additives
were each dissolved in 96% ethanol or water at 50–78 C.
The resulting solutions were ﬁltered and then added to 1
(24.2 g) under stirring. The resulting mixtures were evap-
orated to dryness under reduced pressure (10 Torr, 40 C)
and the resulting solid products were dried in a desiccator
overnight. The residues were ball-milled to give the ﬁnal
products. Experimental data and results for products 5–19
are given in Tables 2 and 3.
General Procedure III: Palmitic Acid Added to a Mixture
of a-D-galactose (1) and Starch (20) and Carbohydrates
Other than a-D-galactose (21–24)
For 20, a-D-galactose (1, 12.1 g) was heated to 60 C and
mixed with a 14.3% w/w starch solution in water (35.0 g)
before addition of the fatty acid solution. For products 21
and 22, a-D-galactose (1) was replaced by 41.3% w/w
solutions (24.2 g) of a-D-xylose and maltodextrin, respec-
tively. For 23 and 24, a-D-galactose (1) was replaced by
22.5% w/w solutions (22.2 g) of glycogen and a-cyclo-
dextrin, respectively. The resulting mixtures were evapo-
rated to dryness under reduced pressure (10 Torr, 40 C).
The resulting solid products were dried in a desiccator
overnight and the residues were ball-milled to give the
products. Experimental data and results for products 20–24
are given in Table 4.
Table 1 A390 for products 1–4 without addition of amphiphiles
a-D-galactose ? carbohydrate 2 (C2) Prod. % C2 A390 t  (s)
a-D-galactose (reference 1, RC1) 1 05 1 6
a-D-xylose 2 0 &00
a-D-galactose ? Starch 3a 20 164 30
3b 50 161 35
3c 80 70 38
a-D-galactose ? Dextran 4a 25 23 54
4b 50 13 48
Milled a-D-galactose (1) is reference product 1 (RC1) and corre-
sponds to the commercial product Echovist. Carbohydrate 1 is
milled a-D-galactose or a-D-xylose. The added carbohydrate is
denoted C2
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Results
The particle size distributions of the solid products 1–24
were in the range of 1–20 lm (Coulter Counter, data not
given). In example, a typical accumulated particle volume
distribution of 18b showed that 90% was\4.4 lm and
10% was\0.5 lm, the mean diameter was 2.2 lm and the
median diameter was 2.1 lm. Based on visual microscopy
observation, the solid particles tended to release air bubble
dispersions in the size range of 1–15 lm, with some larger
bubbles.
For product comparison, two reference compounds were
needed: according to the literature and product descriptions
[7, 13, 14], milled a-D-galactose (1) corresponds to the
commercial product Echovist and was chosen as refer-
ence product 1 (denoted RC1). According to the literature
[8] and public information, the product consisting of a-D-
galactose milled with 0.1% palmitic acid (13a) corresponds
to the commercial product Levovist, and was chosen as
reference product 2 (denoted RC2). The results of the
acoustic characterization expressed as A390 are given in
Tables 1, 2, 3 and 4. The results of the measurement of
A390 after mixing with the carrier liquid are given in
Figs. 1, 2, 3, 4 and 5.
Table 2 A390 for products 5–11
comprising a-D-galactose,
milled with amphiphilic
compounds lacking a carboxylic
acid functionality
For each product, abbreviation
or trivial name of the
amphiphile (A) is followed by
formula, molecular weights and
calculated log P in parentheses.
In the last three columns,
amounts of A, A390 values and
half-times are given. The
chemical names of the
amphiphiles are given under
Materials and Methods
Amphiphile A with trivial name (formula, Mw, log P)
milled with a-D-galactose
Prod. % AA 390 t (s)
DPPC (C40H81NO8P, 736.1, 9.8) 5a 0.1 366 53
5b 1.0 3,712 [500
Na-LS (C12H25NaO4S, 266.4 (anion), 1.8) 6a 0.1 22 23
6b 1.0 67 66
SMO (C24H46O7, 446.6, 5.0) 7a 0.1 &00
7b 1.0 34 26
STO (C60H110O9, 975.5, 21.2) 8a 0.1 6 34
8b 1.0 28 72
HTBCP (Average Mw 8,400, log P n.a.) 9a 0.1 58 21
9b 1.0 74 23
Na-Docusate (C20H37NaO7S, 422.6 (anion), 6.1) 10a 0.1 55 23
10b 1.0 3 0
DOPE (C44H86NO8P, 744.1, 13.6) 11a 0.1 343 [500
11b 1.0 552 72
Table 3 A390 values of
products 12–19 comprising a-D-
galactose,
milled with amphiphilic
compounds possessing a
carboxylic acid functionality
Milled a-D-galactose milled
with 0.2% palmitic acid (13b)i s
reference product 2 (RC2) and
corresponds to the commercial
product Levovist. For each
product, abbreviation or trivial
name of the carboxylic acid C is
followed by the formula,
molecular weight and calculated
log P in parentheses. In the last
three columns, amounts of A,
A390 values and half-times are
given. The chemical names of
the amphiphiles are given under
‘‘Materials and methods’’
Carboxylic acid C, trivial name (formula, Mw, log P)
milled with a-D-galactose
Prod. % C A390 t (s)
Capric acid (C10H22O2, 172.3, 4.0) 12a 0.1 &00
12b 1.0 &00
Palmitic acid (C16H34O2, 256.4, 7.0) reference 2
(RC2) = 13a (0.1% palmitic acid)
13a 0.1 357 31
13b 0.2 871 35
13c 1.0 1,061 107
Hexadecane-dioic acid (C16H34O4, 286.4, 5.1) 14 1.0 474 40
Linolenic Acid (C18H30O2, 278.4, 7.3) 15 1.0 401 79
Behenic acid (C22H44O2, 340.6, 9.9) 16a 0.1 2,745 [500
16b 1.0 4,653 [500
10,12-tricosa-diynoic acid (C23H38O2, 346.6, 9.9) 17 0.2 884 51
Melissic acid (C30H60 O2, 452.8, 13.8) 18a 0.01 322 150
18b 0.1 4,095 [500
18c 1.0 4,564 [500
5b-cholanic acid (C24H40O2, 360.6, 7.7) 19a 0.01 162 47
19b 0.1 1,962 203
19c 1.0 4,048 [500
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results, using A390 as a response parameter. A high log P,
the presence of a-D-galactose and that of a carboxylate
group in the amphiphilic molecule correlates positively
with A390. In addition, the PLS analysis reveals some
interaction effects between parameters. There is a strong
interaction between log P and the presence of a carboxylate
group; an interaction between log P and the presence of
a-D-galactose is also evident from the analysis.
Discussion
As shown in Figs. 1 and 2, the use of other carbohydrates
than a-D-galactose does not improve performance (A390 and
t) as compared with the a-D-galactose-based reference
products RC1 and RC2. The observed signiﬁcant increase
in both A390 and t when a-D-galactose is mixed with 0.1%
of b-cholanic acid (19b), behenic acid (16a), and melissic
acid (18b) compared with RC2 (Fig. 5), correlates well
with the log P values for the acids. The products 16a and
18b show half-time t[500 s compared with t = 31 s
for RC2 (Table 3). For instance, log P for 5b-cholanic,
behenic and melissic acids are calculated to be 7.7, 9.9 and
13.8, respectively. The A390 values for the corresponding
products 19b, 16a and 18b are 1,962, 2,745 and 4,095,
respectively. When the amount of these fatty acids is
increased to 1% (products 16b, 18c and 19c, Table 3,
Fig. 4) the correlation of A390 and t with log P is even
more pronounced.
An interesting comparison is the results for the products
13c, 14 and 15, with 1% (w/w) palmitic acid, hexadec-
anedioic acid and linolenic acid, respectively (Table 3).
Both A390 and t are more than 100% higher for 13c
Table 4 A390 values for products 20–24 different carbohydrates
milled with 0.2% palmitic acid
Carbohydrate milled with
palmitic acid
Product A390 t (s)
a-D-galactose ? Starch 20 142 152
a-D-Xylose 21 706 245
Maltodextrin 22 254 225
Glycogen 23 358 [500
a-Cyclodextrin 24 94 47
Fig. 1 Acoustic attenuation (dB/cm) vs. time (390 s) of carbohydrate
mixtures without amphiphiles added, compared with the reference
standard 1 (RC1), milled a-D-galactose (1). When no amphiphiles are
present, mixing of a-D-galactose with polymeric carbohydrates like
starch or Dextran with Mw 20 kD only slightly increases A390
compared with RC1
Fig. 2 Acoustic attenuation (dB/cm) vs. time (390 s) of different
carbohydrates with 0.2% palmitic acid compared with the reference
standard 2 (RC2), milled a-D-galactose with 0.2% palmitic acid
(13b). Adding palmitic acid to different carbohydrates shows that
A390 of RC2 is superior for the ﬁrst 100 s compared with the products
containing maltodextrin, glycogen and a-cyclodextrin with the same
amount of palmitic acid
Fig. 3 Acoustic attenuation (dB/cm) vs. time (390 s) of a-D-galact-
ose with 1% of different amphiphiles, surfactants and linolenic acid
compared with a-D-galactose containing 1% palmitic acid. The
intensity and duration of the acoustic attenuation of all products
containing 1% amphiphiles with various log P values, but lacking
carboxylic acid functionality, is signiﬁcantly lower than for RC2
590 J Surfact Deterg (2011) 14:585–593
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bend its lipophilic chain at the gas–water interface,
reducing the lipophilic interaction. For linolenic acid (15),
a highly unsaturated carboxylic acid with a log P compa-
rable to palmitic acid, A390 is at the level of 14 and with a
half life of only 79 compared with 107 for 13c (Table 3 and
Fig 3). This may be due du the high number of cis double
bonds in linolenic acid, giving a non-linear conformation of
the lipophilic chain, reducing the hydrophobic interactions
between the hydrocarbon chains [15].
The PLS analysis illustrated by the regression coefﬁ-
cient plot (Fig. 6) provides further support for the trends
observed in the A390 plots. An absolute high and stable
regression coefﬁcient for many principal components
indicates a robust effect of the actual descriptor (Fig. 6).
The strongest positive correlation is shown between am-
phiphiles possessing a carboxylic acid functionality and
high log P added to a-D-galactose. This points at fatty acids
with a number of carbon atoms[20, in good compliance
with the experimental data. These data are further
strengthened by the experimental results for amphiphiles
with high log P but lacking the carboxyl functionality; all
have low A390 (e.g. the phospholipid-based product 11).
Mw alone has negligible effect on A390 as shown by its
regression coefﬁcient (Fig. 6). The good correlation
between predicted and observed A390 values (Fig. 7) shows
that a suitable model explaining the main effects on A390
has been established. The reliability of the PLS estimated
trends was also tested by regressing various logarithmic
transformations of the response having a more uniform
variation than the original A390, and unimportant regression
coefﬁcients were successively removed. This process gave
similar regression coefﬁcients patterns as shown in Fig. 6
regarding the most important parameters affecting A390 as
well as t.
Ultrasonic waves are heavily attenuated at gas–water
interfaces [1]. It has earlier been reported [16] that a linear
correlation between ultrasonic attenuation and interfacial
area in a gas–liquid bubble column could be used to esti-
mate the total interfacial area in the system. The same
acoustic phenomenon was used in the present study to
establish a method to monitor the amount and lifetime of
bubble populations generated by milled carbohydrates.
The amphiphiles in the present study with the highest
log P are practically insoluble in water [17]. Thus, when
the ethanolic solutions of the amphiphiles are added to the
aqueous carbohydrate solutions (products 5–19), colloidal
suspensions may form. It was shown in a study of fatty acid
particle formation in water containing a surfactant [18] that
the particle size of such suspensions depended on the chain
length of the fatty acid. Gas bubbles have an afﬁnity for
lipophilic particulate surfaces providing stabilization of the
gas phase [19–22], providing one possible mechanism for
the observed bubble stabilizing effect during the dissolu-
tion of the carbohydrate-amphiphile admixtures. However,
a more plausible mechanism is the formation of fatty acid
Langmuir ﬁlms at the gas–water interface, systems exten-
sively described in the literature [17, 23–26]. If the
amphiphilic compounds are spread on the gas–water
interface, reduction of surface tension would result, as
shown by isotherm studies in the cited literature. Reduced
surface tension would increase bubble stability, explaining
the observations in the present study. It is also well known
from reports of investigation of aerosol systems that fatty
acids with high log P tend to be organized at the gas–liquid
as Langmuir ﬁlms [17]. In that study, it was shown that
chain length and the carboxylic acid functionality were
important for the interfacial lifetime of the Langmuir ﬁlms.
One question arising is how the fatty acids with the highest
log P and very limited solubility in water could achieve a
Fig. 4 Acoustic attenuation (dB/cm) vs. time (390 s) of a-D-galact-
ose with 1% of different amphiphiles, higher fatty acids and DPPC
Fig. 5 Acoustic attenuation (dB/cm) vs. time (390 s) of a-D-galactose
with 0.2% of different amphiphiles. When a-D-galactose is milled
with 0.1% of b-cholanic acid (19b), behenic acid (16a), and melissic
acid (18b), a signiﬁcant increase in A390 compared with RC2 is
observed
J Surfact Deterg (2011) 14:585–593 591
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the carbohydrate formulations. The ultrasonic inﬂuence in
the present experiments may aid the dissolution process, as
described in literature for systems comprising substances
with low water-solubility [27].
Conclusion
In conclusion, the response parameters A390, expressing the
amount of gas-phase present during 390 s, and the bubble
half-time t was shown to be useful main parameters in a
screeningmethodforincreasedpersistenceoftheultrasound
contrasteffectinvitro.Usingtheseparameters,itwasshown
that the persistence and amount of released gas bubbles in
formulations used in the commercial carbohydrate-based,
gas-releasing available and improved ultrasound contrast
agents (Echovist and Levovist respectively) could be
improved more than 10 times using fatty acids with a higher
log P relative to palmitic acid. Saturated fatty acids with
chain length higher than 20 carbon atoms are commercially
available, are found in many nutritional products and should
ﬁnd convenient use in pharmaceutical products. Speciﬁ-
cally, the increases in A390 and t shown for product 19b-c,
and especially products 16a-b and 18b-c containing
5b-cholanic, behenic and melissic acid, respectively, are
results that encourage further research and in vivo studies.
Studies are ongoing to investigate the in vivo properties of
the most promising test substances.
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